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Abstract
Several treatment options corresponding to the grade of keratoconus have been established. These are ultra-violet
corneal crosslinking and intracorneal ring segments for mild to moderate keratoconus, and penetrating keratoplasty
or deep anterior lamellar keratoplasty for the more advanced cases of keratoconus.
Bowman layer transplantation was developed as a procedure for patients with advanced, progressive keratoconus.
The technique consists of transplanting an isolated donor Bowman layer into a mid-stromal pocket of a keratoconic
cornea resulting in corneal flattening and stabilization against further ectasia. Thus, it aims at corneal stabilization in
eyes with advanced keratoconus, and enabling continued contact lens wear for normal visual functionality. By
being a sutureless procedure and using an acellular graft, it potentially avoids commonly known suture and graft-
related complications of penetrating or deep anterior lamellar keratoplasty.
The treatment seems to be a promising option in the management of advanced keratoconus in order to postpone
or prevent a more invasive corneal surgery, while minimizing the risk of complications and allowing less stringent
surveillance and less intensive medical therapy.
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Background
Several treatment options corresponding to the grade of
keratoconus (KC) have been established [1]. These are
ultra-violet corneal crosslinking (UVCXL) and intracorneal
ring segments (ICRS) for mild to moderate KC, and pene-
trating keratoplasty (PK) or deep anterior lamellar kerato-
plasty (DALK) for the more advanced cases of KC [2–9].
UVCXL has been introduced in 2003 and its purpose is
to freeze the evolution of the disease and postpone or
prevent the need for corneal transplantation [2, 10, 11]. The
results of the procedure have been encouraging, with ap-
proximately 80–90% of treated eyes reaching topographic
stability [3], but the procedure may only be indicated in cor-
neas with minimum corneal thickness of 400 μm. Although
techniques are being developed to treat thinner corneas as
well [4], it may be less suitable for more advanced KC, given
that the rates of treatment failure and vision-threatening
complications may increase [5].
The use of ICRS for KC was first reported in 2000 [6].
By reshaping the cornea, the segments may improve the
corneal optics, while it may also confer some amount of
support, possibly helping in postponing or avoiding cor-
neal transplantation [7, 12]. Nevertheless, eyes with se-
vere corneal thinning and steepening may be less eligible
for the procedure [8].
For patients with advanced KC, PK and DALK are still
currently used as the only options of treatment, in spite
of well-known postoperative difficulties such as wound
healing and suture related problems, tectonic instability,
the risk of allograft rejection, a chronic steroid use that
may predispose to cataract formation and glaucoma, and
disappointing visual results [1, 9]. Advanced KC patients
may, however, still have a subjectively acceptable contact
lens (CTL)-corrected vision [13]. Consequently, they
may still profit from reshaping the cornea and prevent-
ing further KC progression to enable continued contact
lens wear with normal daily visual performance.
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In KC corneas, changes in the organization of the stro-
mal lamellae and unequal distribution of the collagen fi-
brillar mass, particularly around the apex of the cone,
have been described [14]. Confocal microscopy studies
have demonstrated a reduction in the number of kerato-
cytes and stromal lamellae in KC compared to normal
subjects, the reduction being greater in more advanced
cases of KC [15]. Furthermore, the Bowman layer (BL)
of these corneas consistently shows fragmentation,
which are then filled with stromal collagen [16].
The physiologic purpose of the BL remains thus far
somewhat unclear because numerous eyes have had their
BL disrupted by laser refractive procedures without any sig-
nificant consequences, and congenital absence of the BL
has been reported in normal corneas [17]. On the other
hand, it has also been suggested that the BL may be the
strongest biomechanical element of the human cornea
followed by the anterior third of the cornea [18]. As such,
the BL may play a structural role in maintaining the shape/
tectonic stability in KC corneas. Consequently, we hypothe-
sized that a surgical approach in which the possible func-
tionality of the BL in stabilizing the cornea could be
restored, could potentially reinforce these thin and structur-
ally fragile corneas. We developed a surgical technique in
which an isolated BL graft is positioned inside a recipient
KC cornea, sandwiched between the stromal layers above
and below, while reshaping the anterior corneal surface in a
flatter position [19]. The main treatment objective of the
surgery, which was first described in 2014 and is called BL
transplantation [19], is halting progression and reducing
corneal steepness, which in turn, allows continued daily
CTL wear (mainly scleral lenses) and preserve the present
CTL-corrected vision, potentially postponing or avoiding
the need for PK or DALK [20, 21]. By being a sutureless
procedure and using an acellular graft, it potentially avoids
all commonly known suture and graft-related complications
Fig. 1 Surgical views of a Bowman layer (BL) graft preparation. A donor globe is mounted on a globe holder or a donor corneo-scleral rim is
placed on an artificial anterior chamber with its epithelial side up. Corneal epithelial cells should be removed, after which, (a) just within the
limbal area a superficial incision can be made over 360° with a 30G needle. (b) A peripheral donor BL edge is then lifted from the underlying
anterior stroma using a single tip of a McPherson forceps. (c-e) Subsequently, by grasping the BL edge with the McPherson forceps via gentle
slow movements in a circular manner, the entire BL is carefully peeled away to free the tissue from its underlying attachments. After preparation,
the BL graft is evaluated and can be trephined if needed. (f) The BL graft tends roll into a single or double roll due to tissue elasticity
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of earlier techniques such as penetrating or deep anterior
lamellar keratoplasty (PK and DALK, respectively) [1].
BL transplantation is indicated in eyes with progressive
advanced keratoconus that are no longer eligible for
UVCXL or ICRS given the corneal thickness or steep-
ness. Potential candidates should have “acceptable”
CTL-corrected vision and documented KC progression.
What represents “acceptable” vision is likely to depend
on the patient: in our experience, many patients would
rather like to preserve the vision they have than undergo
a PK/DALK with its risks and postoperative burden.
Review
Graft preparation
BL graft preparation was initially described in 2010 [22],
and has remained largely unchanged since: BL grafts can
either be prepared from whole donor globes (obtained
less than 24 h postmortem, with corneas considered in-
eligible for PK) or from an anterior corneal button after
stripping the Descemet membrane and endothelium for
use in patients who were indicated for Descemet Mem-
brane Endothelial Keratoplasty (DMEK) [23]. Donor
globes or anterior corneal buttons (epithelial side up)
are mounted on a globe holder or artificial anterior
chamber, respectively, and the epithelium is removed
using surgical spears (Fig. 1). Then, a 30-gauge needle is
used to incise the BL, just within the limbal area, 360°
around. The peripheral BL can be lifted and grasped
with a McPherson forceps and then carefully peeled free
from the underlying stroma, obtaining a 9- to 11-mm
diameter BL graft (Fig. 1) [23]. Due to the inherent elas-
ticity of the tissue, BL grafts tend to curl into a single or
double roll with the epithelial border at the outside (Fig.
1). In the end, the donor BL graft is rinsed in 70% alco-
hol for 30 s and stored in organ-culture medium until
the time of transplantation [23].
Recently, the use of a femtosecond laser for donor BL
preparation has been evaluated. Preliminary results were en-
couraging, showing that the laser cut tissues demonstrated
smoother / more regular edges compared to those prepared
manually. However, the femtosecond laser prepared grafts
were significantly thicker, containing some amounts of an-
terior stroma. The potential optical impact of these differ-
ences in graft morphology is presently unknown [24].
Surgical technique
BL transplantations are performed under local anesthesia
with the patient positioned in anti-Trendelenburg pos-
ition, after an ocular massage and a Honan’s balloon for
10 min. The first step of the surgery is a superior conjunc-
tival peritomy. Then 1–2 mm outside the limbus, a 5 mm
partial thickness scleral tunnel is made and dissected up
into the clear cornea using a crescent knife. Subsequently,
a paracentesis is created and the anterior chamber is filled
with air (Fig. 2) [19]. After this step, a manually dissected
stromal pocket is created over 360° up to the limbus,
using the technique as described for manual DALK
[25]. For BL transplantation, a 50% dissection depth,
which can be found using the “air-endothelial reflex”
[25] is preferred (to minimize the risk of unintentional
Fig. 2 Intraoperative video-stills of a Bowman layer (BL)
transplantation. (a) A scleral tunnel incision and (b) paracenteses
are made. (c) Then, the anterior chamber is filled with air, and
(d-f) a manually dissected mid-stromal pocket is created, using
different sizes spatulas. (f) As an indication for the dissection
depth, the ‘thin black line’ alongside the spatula can be used.
After removing most air from the anterior chamber, (g, h) the BL
graft is inserted into the pocket atop of a glide, and (i) then
carefully unfolded and centered with an 30G cannula. (j) After
complete unfolding and positioning, the BL graft is sandwiched
between the anterior and posterior stromal layers. No sutures are
necessary to fixate the graft or to close the tunnel incision
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anterior or posterior perforation) (Fig. 2). Once this has
been accomplished, most air is removed from the anter-
ior chamber, and a surgical glide is threaded through
the corneo-scleral incision into the dissected pocket. At
the same time, the BL graft is again immersed in 70%
ethanol for 30 s to remove all remnant cellular material,
after which it is thoroughly rinsed with balanced salt
solution (BSS), stained with Trypan blue, and placed
atop of the glide, where it is pushed into the eye with
the help of a cannula (Fig. 2). Once the graft is inside
Fig. 3 Pre- and postoperative clinical images of an eye that underwent BL transplantation. (a-f) Slit-lamp pictures, (g-i) anterior corneal
topography and (j-l) posterior corneal elevation maps of an eye, (a, d, g, j) before and (b, e, h, k) at one month and (c, f, i, l) 5 years after
Bowman layer (BL) transplantation. Slit-lamp imaging demonstrates (a) a clear cornea preoperatively, as well as postoperatively at (b) 1 month
and (c) 5 years, while (e, f) the BL graft is visible as a thin white line within the host stroma (white arrows). (g-i) Corneal topography shows a
flattening from (g) preoperatively to (h) the 1 month follow-up, and (h, i) stabilization thereafter. Likewise, (j-l) a decrease in posterior corneal
elevation can be noticed from (j, k) before to 1 month postoperatively, after which (k, l) no changes occur up to 5 years after BL transplantation
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the stromal pocket, the glide is removed, and the graft
is unfolded and positioned by manipulating it with the
cannula, jets of BSS, and indentation on the corneal
surface (Fig. 2). After a complete unfolding and posi-
tioning of the graft, the eye is pressurized with BSS, the
conjunctiva is repositioned to the superior limbus and
the eye is patched. No sutures are required.
Potential difficulties in the learning curve of the
surgical technique are the midstromal manual dissec-
tion of these thin KC corneas, together with the graft
handling. As the same manual dissection technique is
used as with manual DALK, some experience with
the manual DALK-surgery could be beneficial for the
learning curve in performing a BL transplantation.
Furthermore, familiarity with DMEK may aid in BL
graft handling.
Postoperative medications include antibiotics for one
week and a corticosteroid for the first month, after
which the steroid may be tapered according to the sur-
geon’s discretion [19, 20].
Clinical outcomes
BL transplantation is a relatively new KC treatment op-
tion with limited literature available. Single center clin-
ical outcomes for BL transplantation are available up to
7 years after the surgery [21, 26]. In a first series of eyes
in which BL transplantation was performed, operated
eyes showed a significant flattening of the cornea of 8–9
D (on average) in maximum keratometry values in the
first postoperative month, after which stabilization of
the ectasia has been observed (Fig. 3) [20, 21]. Likewise,
the posterior corneal curvature flattens and stabilizes
thereafter (Fig. 3) [20]. Meanwhile, on slit-lamp examin-
ation the graft remains only vaguely visible as a thin
white line (Fig. 3) [19–21].
Within a reported 5-year follow-up period, KC disease
progression and/or severe complications could be avoided
in 84% of the eyes [21]. The flattening of the cornea was ac-
companied by an improvement in spectacle-corrected visual
acuity and a decrease in corneal higher order aberrations
(especially spherical aberration) [27]. The mid-stromal posi-
tioning of the BL graft may however give some increase in
corneal backscatter [27], which was found to occur up to
5 years after BL transplantation [21], and is possibly initiated
by interface irregularities and/or differences in refractive in-
dices between the BL graft and host stroma. Nevertheless,
the clinical impact of this rise in corneal densitometry may
be minimal given the objective and subjective lack of visual
disturbance. In fact, CTL-corrected vision showed no
changes from before to after BL transplantation [20, 21],
and patients sometimes even experienced an improvement
in their functional vision, since CTL wear became more
comfortable as a result of the large amount of postoperative
corneal flattening.
Complications
So far, our experience with BL transplantation showed
that the surgery may be a promising, minimally invasive
approach to arrest KC progression; surgical manipula-
tions are limited to the pocket within the recipient cor-
neal stroma, no surface incisions are made, and no
sutures are used to fixate the graft. Therefore, unlike PK
or DALK, postoperative ocular surface complications or
suture related problems do not occur. Furthermore,
since the BL tissue is acellular, allograft reaction may be
unlikely and topical steroids may be rapidly discontin-
ued, minimizing the risk of glaucoma development or
cataract formation.
The main intraoperative complication (the only en-
countered) may be a Descemet membrane perforation
while dissecting the mid-stromal pocket, which is de-
scribed to occur in 10% (2 out of a first series of 22
eyes) of the originally operated cohort of BL trans-
plantation eyes [19, 20]. As with DALK, these perfo-
rations may be managed expectantly by aborting the
operation, to allow healing, and re-attempting again
at a later date. Alternatively, the surgeon may proceed
with PK, depending on the size and position of the
perforation [28].
Postoperatively, an unexpected complication is the oc-
currence of a corneal hydrops at 4.5, 6 and 6.5 years
postoperatively in two patients (3 eyes), in a series of 20
eyes after successful BL transplantation. These patients
had a history of severe eye rubbing and atopy and devel-
oped the hydrops despite no evidence of progressive
steepening or thinning [26]. Therefore, also after BL
transplantation, patients should be counseled about the
possible impact of eye-rubbing, and allergies may need
closer monitoring and treatment. No other postoperative
complications have been observed [21, 26].
Conclusion
BL transplantation aims at corneal stabilization in eyes
with advanced KC, enabling continued CTL wear for
normal visual functionality. The treatment seems like a
promising option for the management of advanced KC
in order to postpone or prevent a more invasive corneal
surgery, while minimizing the risk of (long-term) com-
plications and allowing less stringent surveillance and
less intensive medical therapy.
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